Comparable stake leader
Iroquois Capital Management, LLC
SEC ownership of Clearmind Medicine Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001892500.
Disclosed value leader
Iroquois Capital Management, LLC
Comparable rows
2/8
Latest evidence
30 Jun 2026
- Public ticker
- CMND on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Iroquois Capital Management, LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
2 of 8
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Iroquois Capital Management, LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001892500
- Issuer location
- Vancouver, British Columbia, Canada (Federal Level)
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Clearmind Medicine Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Iroquois Capital Manageme...
Disclosed value leader
Iroquois Capital Manageme...
Comparable rows
2/8
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 10%
6 rows are not safely comparable across share classes.
13D/G row: Iroquois Capital Management, LLC
Quick read
Iroquois Capital Management, LLC leads the comparable SEC ownership view at 10%.
2 of 8 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Iroquois Capital Management, LLC's linked filing trail.
Comparable ownership
Top 2
Iroquois Capital Management, LLC
10%
AdvisorShares Trust
4.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 8 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Iroquois Capital Management, LLC |
13D/G
Richard Abbe
|
10%
Reported 13D/G
· 30 Jun 2026
|
$689,867
346,667 shares
|
$0 | 30 Jun 2026 |
| AdvisorShares Trust |
13D/G
|
4.8%
Reported 13D/G
· 30 Jun 2025
|
$177,102
205,933 shares
|
$0 | 30 Jun 2025 |
| HRT FINANCIAL LP |
3/4/5
13F
10%+ Owner · Company
|
—
mixed-class rows
|
$612,546
184,845 shares
mixed-class rows
|
+$211,815 | 10 Jun 2026 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
denominator unverified
|
$25,762
11,710 shares
|
— | 30 Jun 2026 |
| AdvisorShares Investments LLC |
13F
Company
|
—
denominator unverified
|
$2,572
1,169 shares
|
— | 30 Jun 2026 |
| MORGAN STANLEY |
13F
Company
|
—
denominator unverified
|
$1,540
700 shares
|
— | 30 Jun 2026 |
| ROYAL BANK OF CANADA |
13F
Company
|
—
denominator unverified
|
$1,000
286 shares
|
— | 30 Jun 2026 |
| Caitong International Asset Management Co., Ltd |
13F
Company
|
—
denominator unverified
|
$2
1 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$211,815.
Buys
$330,335
Insiders: 1
Sells
$118,520
Insiders: 1
Net
+$211,815
Shares: +1,906,437
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 2,159,052
Shares: 252,615
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 2,159,052 | 252,615 | $330,335 | $118,520 | +$211,815 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-1 of 1 reporting-owner rows connected to Clearmind Medicine Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
1
Largest Forms 3/4/5 holder
HRT FINANCIAL LP
Net 12M change
+$211,815
Latest report
10 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | 10%+ Owner | $612,546 | +$211,815 | +53% | Filing P/S | 10 Jun 2026 |
Recent insider transactions for Clearmind Medicine Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Hrt Financial Lp | CMND | Class A Shares | Sale | -21.4% | $73,192 | $3.31 | -22,139 | 81,353 | 16 Jun 2026 | Direct |
| Hrt Financial Lp | CMND | Common Stock | Sale | -2.98% | $10,568 | $3.32 | -3,183 | 103,492 | 15 Jun 2026 | Direct |
| Hrt Financial Lp | CMND | Common Stock | Sale | -1.93% | $7,063 | $3.36 | -2,102 | 106,675 | 12 Jun 2026 | Direct |
| Hrt Financial Lp | CMND | Common Stock | Sale | -10.9% | $27,698 | $0.1230 | -225,191 | 1,838,075 | 11 Jun 2026 | Direct |
| Hrt Financial Lp | CMND | Common Stock | Purchase | $330,335 | $0.1530 | 2,159,052 | 2,063,266 | 10 Jun 2026 | Direct |
* marks a reported price that did not pass the local price check.